Pulse Biosciences insider buying signals confidence but cash runway worries: learn what Robert Duggan’s recent 660k‑share purchase means for investors.
Pulse Biosciences insider trading shows CEO confidence in its AF therapy pipeline—insider buys at 52‑week highs signal long‑term upside amid growing commercial momentum.